Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
ACW Announcements
ACW third positive XanaMIA trial data…
ACW
ACTINOGEN MEDICAL LIMITED
Market sensitive
ACW third positive XanaMIA trial data committee review
Date and time
18 June 2026 at 6:57 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
ACW announcement history
Recent ACW announcements
Appendix 3Y - Dr George Morstyn
Application for quotation of securities - ACW
Appendix 3Y-Malcolm McComas
Application for quotation of securities - ACW
ACW webinar today, The future of Alzheimers treatment
Updated Securities Trading Policy